IL83474A0 - Homogeneous recombinant immune interferon fragments and its preparation,a replicable microbial expression vehicle containing it and its preparation,a microorganism transformed by said expression vehicle,and pharmaceutical compositions containing said immune interferon fragment - Google Patents

Homogeneous recombinant immune interferon fragments and its preparation,a replicable microbial expression vehicle containing it and its preparation,a microorganism transformed by said expression vehicle,and pharmaceutical compositions containing said immune interferon fragment

Info

Publication number
IL83474A0
IL83474A0 IL83474A IL8347487A IL83474A0 IL 83474 A0 IL83474 A0 IL 83474A0 IL 83474 A IL83474 A IL 83474A IL 8347487 A IL8347487 A IL 8347487A IL 83474 A0 IL83474 A0 IL 83474A0
Authority
IL
Israel
Prior art keywords
preparation
expression vehicle
immune interferon
pharmaceutical compositions
microorganism transformed
Prior art date
Application number
IL83474A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL83474A0 publication Critical patent/IL83474A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL83474A 1986-08-13 1987-08-07 Homogeneous recombinant immune interferon fragments and its preparation,a replicable microbial expression vehicle containing it and its preparation,a microorganism transformed by said expression vehicle,and pharmaceutical compositions containing said immune interferon fragment IL83474A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619725A GB8619725D0 (en) 1986-08-13 1986-08-13 Homogenous interferon fragments

Publications (1)

Publication Number Publication Date
IL83474A0 true IL83474A0 (en) 1988-01-31

Family

ID=10602667

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83474A IL83474A0 (en) 1986-08-13 1987-08-07 Homogeneous recombinant immune interferon fragments and its preparation,a replicable microbial expression vehicle containing it and its preparation,a microorganism transformed by said expression vehicle,and pharmaceutical compositions containing said immune interferon fragment

Country Status (21)

Country Link
EP (1) EP0256424B1 (de)
JP (1) JPS6349098A (de)
KR (1) KR880002996A (de)
AR (1) AR244808A1 (de)
AT (1) ATE67783T1 (de)
AU (1) AU607930B2 (de)
DE (1) DE3773295D1 (de)
DK (1) DK377787A (de)
ES (1) ES2051714T3 (de)
FI (1) FI873512L (de)
GB (1) GB8619725D0 (de)
GR (1) GR3003417T3 (de)
HU (1) HU202920B (de)
IE (1) IE60670B1 (de)
IL (1) IL83474A0 (de)
MC (1) MC1847A1 (de)
NO (1) NO174631C (de)
NZ (1) NZ221374A (de)
PH (1) PH27432A (de)
PT (1) PT85538B (de)
ZA (1) ZA875819B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus
DE69104619T2 (de) * 1990-08-31 1995-04-13 Schering Corp Verwendungsmethoden von humanem Gammainterferon 4-134.
DE4036856C1 (de) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US7959910B2 (en) 2000-07-31 2011-06-14 Biolex Therapeutics, Inc. C-terminally truncated interferon alpha variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
AU2003239774A1 (en) 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
US20060024272A1 (en) 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788398B2 (ja) * 1983-10-17 1995-09-27 サントリー株式会社 新規生理活性ポリペプチドおよびその製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
JPS60172999A (ja) * 1983-12-20 1985-09-06 Suntory Ltd 新規な塩基性ポリペプチドおよびその製造法
DK168016B1 (da) * 1983-12-26 1994-01-17 Kyowa Hakko Kogyo Kk Derivat af humant interferon-gamma-polypeptid
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
WO1985005618A1 (fr) * 1984-06-06 1985-12-19 Takeda Chemical Industries, Ltd. Procede de preparation de derives de l'interferon
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
JPS6163696A (ja) * 1984-09-05 1986-04-01 Asahi Chem Ind Co Ltd 新しいペプチド
JPS61108397A (ja) * 1984-10-31 1986-05-27 Green Cross Corp:The インタ−フエロン−γ蛋白質の製造法
JPS62289600A (ja) * 1986-02-18 1987-12-16 Kanegafuchi Chem Ind Co Ltd インタ−フエロン−γ及びその製造方法

Also Published As

Publication number Publication date
AU607930B2 (en) 1991-03-21
ES2051714T3 (es) 1994-07-01
GB8619725D0 (en) 1986-09-24
EP0256424A1 (de) 1988-02-24
PH27432A (en) 1993-06-21
AU7668687A (en) 1988-05-19
IE60670B1 (en) 1994-08-10
NO873389L (no) 1988-02-15
ZA875819B (en) 1988-02-15
DE3773295D1 (de) 1991-10-31
DK377787A (da) 1988-02-14
DK377787D0 (da) 1987-07-20
NO174631C (no) 1994-06-08
NO873389D0 (no) 1987-08-12
MC1847A1 (fr) 1988-09-30
JPS6349098A (ja) 1988-03-01
GR3003417T3 (en) 1993-02-17
EP0256424B1 (de) 1991-09-25
FI873512A7 (fi) 1988-02-14
HUT47148A (en) 1989-01-30
NZ221374A (en) 1990-07-26
PT85538B (pt) 1990-06-29
NO174631B (no) 1994-02-28
KR880002996A (ko) 1988-05-13
FI873512A0 (fi) 1987-08-13
IE872160L (en) 1988-02-13
PT85538A (en) 1987-09-01
HU202920B (en) 1991-04-29
ATE67783T1 (de) 1991-10-15
AR244808A1 (es) 1993-11-30
FI873512L (fi) 1988-02-14

Similar Documents

Publication Publication Date Title
AU1496288A (en) Recombinant ricin toxin fragments
AU7831787A (en) Improved recombinant expression
AU1628895A (en) Recombinant virus
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
IL83474A0 (en) Homogeneous recombinant immune interferon fragments and its preparation,a replicable microbial expression vehicle containing it and its preparation,a microorganism transformed by said expression vehicle,and pharmaceutical compositions containing said immune interferon fragment
IL76732A (en) Injectable pharmaceutical compositions containing lyophilized anthracycline glycosides,their preparation and some new such lyophilized compositions
NZ209590A (en) Gamma interferon analogue, preparation and pharmaceutical composition
IL85712A0 (en) Lyophilized lymphokine composition
IL84484A0 (en) T-cell suppressor protein in pure form,its preparation by recombinant methods and pharmaceutical compositions containing it
NZ220418A (en) A pharmaceutical composition adapted for g.i. resorption comprising a polypeptide and a monosaccharide or sugar alcohol and/or a polyoxylakylene ether
IL89778A (en) Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them
IL95618A0 (en) Recombinant aprotinin variants,their preparation and medicaments containing them
AU7440087A (en) Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli
IL76956A (en) Antibiotic polypeptide,its preparation and pharmaceutical compositions containing it
IL88378A (en) Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
NZ220744A (en) 6-substituted 1,2-methylenandrost-4-ene-3,17-diones and pharmaceutical compositions
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
NZ209307A (en) Diagnostic product: antigenic peptide produced by recombinant dna techniques
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
ATA264487A (de) Homogene, rekombinante immun-interferonfragmente
IL92316A0 (en) Recombinant interleukin-2 hybrid proteins,their production and pharmaceutical compositions containing them
IE871358L (en) Interferon for carcinoma
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
EP0244427A4 (de) Rekombinantes virus.
AU571460B2 (en) Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide